Vol 2, No 6 (December 2013): Translational Lung Cancer Research

China Lung Cancer Research Highlight

Gefitinib in non-small-cell lung cancer—an old lesson new re-visited
Wolfram C. M. Dempke
Endothelial Dll4-Notch signaling in tumor microenvironment: is there any hidden therapeutic opportunity?
Amit Kumar, Sejal Desai, Badri N. Pandey
Influence of chemotherapy on EGFR mutation status
Yung-Hung Luo, Yuh-Min Chen
EGFR mutation heterogeneity and mixed response to EGFR tyrosine kinase inhibitors of non small cell lung cancer: a clue to overcoming resistance
Jordi Remon, Margarita Majem
Notch signaling: a hero or villain in the war against cancer?
Shireen Chikara, Katie M. Reindl
Personalized maintenance therapy in advanced non-small cell lung cancer
Kazuhiro Asami, Kyoichi Okishio, Tomoya Kawaguchi, Shinji Atagi
The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinoma
Timothy G. Whitsett, Landon J. Inge, Nhan L. Tran
Gene alterations, smoking and histology: when the deeper means the rarer
Giulia M. Stella
RET-targeting molecular stratified non-small-cell lung cancers
Katsuya Tsuchihara
Dll4/Notch1 signaling from tip/stalk endothelial cell specification to stroma-dependent lung tumor inhibition: a flavor of Dll4/Notch1 pleiotropy in tumor cell biology
Maria Felice Brizzi, Paola Defilippi